Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
41
pubmed:dateCreated
2000-11-13
pubmed:databankReference
pubmed:abstractText
Although ectopic expression of the cholecystokinin B/gastrin receptor (CCK-BR) is widely reported in human colorectal cancers, its role in mediating the proliferative effects of gastrin1-17 (G-17) on these cancers is unknown. Here we report the isolation of a novel splice variant of CCK-BR that exhibits constitutive (ligand-independent) activation of pathways regulating intracellular free Ca(2+) ([Ca(2+)](i)) and cell growth. The splice variant (designated CCK-BRi4sv for intron 4-containing splice variant) is expressed in colorectal cancers but not in normal colonic mucosa adjacent to the cancer. Balb3T3 cells expressing CCK-BRi4sv exhibited spontaneous, ligand-independent, oscillatory increases in [Ca(2+)](i), whereas cells expressing wild-type CCK-BR did not. Primary cultures of cells isolated from resected colorectal cancers also exhibited a similar pattern of spontaneous [Ca(2+)](i) oscillations. For both Balb3T3 and primary tumor cells, application of G-17 (10 and 200 nm, respectively) caused an increase in [Ca(2+)](i). Selective CCK-BR antagonists blocked the G-17-stimulated Ca(2+) responses but not the spontaneous [Ca(2+)](i) oscillations. Cells expressing CCK-BRi4sv exhibited an increased growth rate ( approximately 2.5-fold), in the absence of G-17, compared with cells expressing wild-type CCK-BR. The selective pattern of expression, constitutive activity, and trophic action associated with CCK-BRi4sv suggest that this variant may regulate colorectal cancer cell proliferation though a gastrin-independent mechanism.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0021-9258
pubmed:author
pubmed:issnType
Print
pubmed:day
13
pubmed:volume
275
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
32122-8
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:10913157-3T3 Cells, pubmed-meshheading:10913157-Alternative Splicing, pubmed-meshheading:10913157-Amino Acid Sequence, pubmed-meshheading:10913157-Animals, pubmed-meshheading:10913157-Base Sequence, pubmed-meshheading:10913157-Binding, Competitive, pubmed-meshheading:10913157-Calcium, pubmed-meshheading:10913157-Calcium Signaling, pubmed-meshheading:10913157-Cell Division, pubmed-meshheading:10913157-Cloning, Molecular, pubmed-meshheading:10913157-Colorectal Neoplasms, pubmed-meshheading:10913157-Female, pubmed-meshheading:10913157-Gastrins, pubmed-meshheading:10913157-Gene Expression Regulation, Neoplastic, pubmed-meshheading:10913157-Humans, pubmed-meshheading:10913157-Introns, pubmed-meshheading:10913157-Male, pubmed-meshheading:10913157-Mice, pubmed-meshheading:10913157-Molecular Sequence Data, pubmed-meshheading:10913157-Neoplasm Staging, pubmed-meshheading:10913157-Receptor, Cholecystokinin B, pubmed-meshheading:10913157-Receptors, Cholecystokinin, pubmed-meshheading:10913157-Tumor Cells, Cultured
pubmed:year
2000
pubmed:articleTitle
Human colorectal cancers express a constitutively active cholecystokinin-B/gastrin receptor that stimulates cell growth.
pubmed:affiliation
Departments of Surgery, Physiology and Biophysics, and Internal Medicine, the University of Texas Medical Branch, Galveston, Texas 77555, USA. mhellmic@utmb.edu
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't